TerraBioGen Announces Cornell University Study Results

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR
DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.


TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of
proprietary technologies for the production of organic-based, high-value
agricultural products from organic wastes, announces the results of recent
studies done by Cornell University. 


The study conducted by Cornell University's Department of Horticulture was
designed to assess the ability of TerraBioGen's liquid LC200, applied at several
rates and intervals, to reduce golf fairway turf nutrient requirements. Standard
fertilizer inputs were applied at 100, 75, 50 and 25 percent of normal rates
required to produce acceptable quality turf. LC200 was applied at three rates
every 7, 14, 28 and 56 days. The study showed a complex interaction between the
plant and compounds in LC200, and suggests that normal fertilizer rates can be
reduced as much as 75% with moderate rates of LC200 applied once every two
months during the growing season. Not only does this enhance economic
performance, the reduction of nutrient loading into the environment offers
significant protection of water quality. 


Blair Heffelfinger, President and CEO of TerraBioGen, said, "The Cornell study
reaffirms previous turf grass research indicating that treatment with
TerraBioGen's LC200 will allow for a significant reduction in fertilizer input
without noticeably impacting turf quality. This is a win-win situation in that
it provides both economic benefits to the grounds keeper and environmental
benefits to society as a whole." 


About TerraBioGen Technologies

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to
research and development to continue to improve the efficiency of its technology
and the quality of its agricultural products. It is further committed to
developing a world-wide marketing capability to ensure market acceptance of its
products.


This news release contains certain statements that may be deemed
"forward-looking" statements. Forward looking statements are statements that are
not historical facts and are generally, but not always, identified by the words
"expects", "plans", "anticipates", "believes", "intends", "estimates",
"projects", "potential" and similar expressions, or that events or conditions
"will", "would", "may", "could" or "should" occur. Although TerraBioGen believes
the expectations expressed in such forward-looking statements are based on
reasonable assumptions, such statements are not guarantees of future performance
and actual results may differ materially from those in forward looking
statements. Forward looking statements are based on the beliefs, estimates and
opinions of TerraBioGen's management on the date the statements are made. Except
as required by law, TerraBioGen undertakes no obligation to update these
forward-looking statements in the event that management's beliefs, estimates or
opinions, or other factors, should change.


THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR
DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD
IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Terrabiogen Technologies (TSXV:TBG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024